Dr. Paul Sax weighs in on the latest HIV treatment option to receive FDA approval, in
HIV and ID Observations.
The FDA recently approved another once-a-day pill (coformulated tenofovir alafenamide, emtricitabine, rilpivirine) for HIV treatment. In his latest HIV and ID Observations blog post, Dr. Paul Sax discusses how it stacks up against other available options.